PubMed Trending Research Digest — May 12, 2026

Automated digest · 97 articles · 15 research areas · May 12, 2026

Overview

Across this week’s set of papers, a dominant theme is precision targeting—both at the molecular level (e.g., PARP1 inhibition with BBB-penetrant agents, SOD1-directed antisense therapies, TROP2 ADCs, and gene-modulating antibody-oligonucleotide conjugates) and at the systems level (biomarker-guided combinations in NSCLC, proteomics- and imaging-derived risk stratification in kidney disease and HCC, and blood-based immune signatures for predicting checkpoint inhibitor response). Several studies also emphasize mechanism-driven therapy selection: TMZ resistance in glioblastoma is linked to endothelial signaling that promotes macrophage infiltration, while TAM spatial metabolic programs (e.g., SLC2A1) shape CD8+ T-cell function and immunotherapy resistance.

A second major thread is the tumor microenvironment and cell-state control—particularly in colorectal cancer and glioblastoma—where specific immune/stromal populations (ANGPTL2+ CAFs, SPP1+ macrophages, GPNMB+ macrophages with COL6A3+ fibroblasts) accelerate progression, fibrosis, and resistance. Complementing this, broader reviews and mechanistic work highlight how intrinsic survival pathways (autophagy’s stage-dependent roles, ferroptosis evasion via IFI16–HMOX1, and metabolic rewiring in drug-resistant AML) can be exploited to overcome resistance. In parallel, multiple papers extend beyond oncology into translational biology and clinical care: microbiome–immune axes in ulcerative colitis and severe acute pancreatitis, environmental/toxic exposures (microplastics, dietary additives like maltol, and metal mixtures), and advances in neurotechnology and neuromodulation.

Finally, the digest includes several health-systems and guideline-oriented contributions—ranging from sepsis screening and clozapine monitoring to nursing workplace culture and education, and algorithmic clinical decision support (including LLM evaluation). Together, these studies reflect a broader movement toward standardization and measurable outcomes: whether improving safety (radiation in dentistry, cardiac screening yield, perioperative pain control) or enabling scalable interventions (adherence support for hypertension, validated metformin guidance for antipsychotic-induced weight gain).

---

Targeted oncology therapeutics (ADC/ASO/small-molecule inhibitors)

Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial.

In a multicenter, randomized, double-blind, placebo-controlled Phase 3 trial (ADVANCE SC), adults with primary immune thrombocytopenia (ITP) received subcutaneous efgartigimod PH20 (1000 mg) to evaluate efficacy and safety. Subcutaneous efgartigimod PH20 produced clinically meaningful platelet responses compared with placebo in this chronic ITP population with platelet counts <30×10^9/L and prior ITP therapies. This supports SC efgartigimod PH20 as a potential less burdensome alternative to intravenous dosing for managing primary ITP.

Cooper N, Broome CM, Miyakawa Y et al. · American journal of hematology · (2026) · View on PubMed ↗ · Free PDF ↗

Can Gene Therapy Revolutionize Treatment of Neovascular Age-Related Macular Degeneration.

This systematic review and meta-analysis evaluated whether gene therapy—primarily adeno-associated virus (AAV)-based anti-VEGF constructs—improves outcomes for neovascular age-related macular degeneration (nAMD) compared with baseline or standard care. The analysis focused on visual acuity, anatomical response, treatment burden, and safety, addressing the clinical need to reduce frequent anti-VEGF intravitreal injections. The review frames gene therapy as a candidate strategy to improve efficacy and adherence while maintaining safety in nAMD.

Chen KY, Chan HC, Chan CM · American journal of ophthalmology · (2026) · View on PubMed ↗

Antibody-oligonucleotide conjugates in cancer therapy: Potential and Promise.

This review article examined antibody-oligonucleotide conjugates (AOCs) as a next-generation class of targeted cancer therapeutics, contrasting them with antibody-drug conjugates (ADCs) and focusing on gene-modulating oligonucleotide payloads such as siRNA and antisense oligonucleotides (ASO). It highlights the modular design (targeting vehicle, linker, oligonucleotide payload) and the therapeutic rationale for replacing cytotoxic payloads with gene-regulatory mechanisms. The review frames AOCs as promising platforms for precision oncology and outlines key scientific and translational considerations for their development.

Meng Q, Yang M, Xing F et al. · Critical reviews in oncology/hematology · (2025) · 8 citations · View on PubMed ↗

Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis.

This systematic review and network meta-analysis compared monoclonal antibodies targeting amyloid-beta (anti-Aβ mAbs) for cognitive decline in patients with early Alzheimer’s disease using randomized controlled trials up to March 31, 2023. It used R (v4.2.3) with JAGS and STATA (v15.0) to rank anti-Aβ mAbs by efficacy and safety, estimating odds ratios for binary outcomes and mean differences for continuous outcomes. The results are significant for clinicians because they synthesize comparative effectiveness and tolerability across multiple anti-Aβ mAbs to guide selection among therapies for early AD.

Qiao Y, Gu J, Yu M et al. · CNS drugs · (2024) · 34 citations · View on PubMed ↗

Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1.

The study preclinically characterized AZD9574, a blood-brain barrier–penetrant selective PARP1 inhibitor, in vitro and in mouse xenograft models (including intracranial models) and assessed BBB penetration in mouse, rat, and monkey. AZD9574 showed PARP1 inhibition with PARylation blockade and PARP-DNA trapping, penetrated the BBB, and demonstrated antitumor efficacy alone and in combination with temozolomide (TMZ) while being evaluated for hematotoxicity in rat. These findings support AZD9574 as a candidate CNS-active PARP1-targeted therapy for tumors such as glioblastoma where TMZ is standard and BBB penetration is critical.

Staniszewska AD, Pilger D, Gill SJ et al. · Clinical cancer research : an official journal of the American Association for Cancer Research · (2024) · 57 citations · View on PubMed ↗

TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer.

This article described the phase III TROPION-Breast02 clinical trial evaluating datopotamab deruxtecan (Dato-DXd), an anti–TROP2 IgG1 antibody-drug conjugate carrying a topoisomerase I inhibitor payload, in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC). The key finding was the trial design and rationale comparing Dato-DXd versus investigator’s-choice chemotherapy in patients previously untreated for locally recurrent inoperable/metastatic TNBC who are not candidates for PD-1/PD-L1 inhibitors. Scientifically and clinically, it sets up a direct efficacy/safety test of a TROP2-targeted ADC in a high-need TNBC population where prognosis remains poor.

Dent RA, Cescon DW, Bachelot T et al. · Future oncology (London, England) · (2023) · 52 citations · View on PubMed ↗ · Free PDF ↗

---

Cancer biology & tumor microenvironment (TME) & metastasis

Multi-omics and machine learning reveal DPPC as a key contributor to colorectal cancer progression and tumor immune microenvironment remodeling.

This study used integrated multi-omics analysis, including two-sample Mendelian randomization across 1400 metabolites and 91 inflammatory cytokines, plus single-cell transcriptomics and machine learning, to identify drivers of colorectal cancer (CRC) progression and immune microenvironment remodeling. It found that DPPC (a phosphatidylcholine metabolite) is a key contributor to CRC progression and tumor immune microenvironment remodeling, supported by experimental validation. The work suggests DPPC as a mechanistic candidate and potential biomarker/target for CRC-associated immune dysregulation.

Li X, Dong H, Jin Z et al. · Journal of translational medicine · (2026) · View on PubMed ↗ · Free PDF ↗

Endothelial cells sense temozolomide resistance to facilitate monocyte-derived macrophage infiltration in glioblastoma.

This study investigated how temozolomide (TMZ) resistance in patient-derived glioblastoma organoids (GBOs) alters endothelial-cell signaling to promote monocyte-derived macrophage (MDM) infiltration, with a focus on mesenchymal and recurrent GBM. The key finding is that endothelial cells “sense” TMZ resistance and thereby facilitate MDM recruitment, identifying molecular drivers upregulated in TMZ-resistant recurrent GBOs as potential therapeutic targets to block this infiltration. This mechanistic link between TMZ resistance and the GBM immune microenvironment supports strategies aimed at disrupting macrophage trafficking to improve outcomes in recurrent GBM.

Gao W, Huang J, Deng K et al. · Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · (2026) · 4 citations · View on PubMed ↗ · Free PDF ↗

Spatial-reprogramming derived GPNMB+ macrophages interact with COL6A3+ fibroblasts to enhance vascular fibrosis in glioblastoma.

This study analyzed glioblastoma (GBM) tumor microenvironment organization to determine how spatially reprogrammed GPNMB+ macrophages interact with COL6A3+ fibroblasts to drive vascular fibrosis, including in the context of resistance to neoadjuvant immune checkpoint blockade (ICB) plus antiangiogenic therapy. The key finding is that integrated single-cell and spatial transcriptomics identify a specific macrophage–fibroblast spatial axis (GPNMB+ macrophages with COL6A3+ fibroblasts) that enhances vascular fibrosis, validated using multiplex immunohistochemistry and atomic force microscopy. This provides a mechanistic targetable pathway to counteract ICB/antiangiogenic resistance by disrupting pro-fibrotic stromal crosstalk in GBM.

Du Y, Long X, Li X et al. · Genome medicine · (2025) · 7 citations · View on PubMed ↗ · Free PDF ↗

RNA m1A methyltransferase TRMT61A promotes colorectal tumorigenesis by enhancing ONECUT2 mRNA stability and is a potential therapeutic target.

This study investigated the RNA m1A methyltransferase TRMT61A in colorectal cancer (CRC) to determine whether it promotes tumorigenesis by regulating ONECUT2 mRNA stability and to assess TRMT61A as a therapeutic target. The key finding is that TRMT61A increases ONECUT2 mRNA stability (via m1A-related mechanisms), promoting CRC growth across cell lines, patient-derived organoids, xenografts, and transgenic mouse models, with mechanistic support from integrated m1A-seq and RNA-seq analyses. Therapeutically, nanoparticle-based small interfering RNA (siRNA) targeting TRMT61A is positioned as a potential strategy to suppress CRC progression.

Zhang X, Qin N, Ji F et al. · Cancer communications (London, England) · (2025) · 2 citations · View on PubMed ↗ · Free PDF ↗

The immune microenvironment of colorectal cancer.

This review summarized how the colorectal cancer (CRC) tumor microenvironment (TME) governs immune evasion and therapy response, emphasizing why only a subset of patients benefits from immune checkpoint blockade (ICB). The key finding is that immune-activated, microsatellite unstable CRC responds to ICB, whereas the predominant microsatellite-stable group remains largely non-responsive due to an immunosuppressed, lowly immunogenic TME. The clinical significance is that rational TME modulation strategies are needed to convert microsatellite-stable CRC into an immune-activated state that can respond to immunotherapy.

Kennel KB, Greten FR · Nature reviews. Cancer · (2025) · 29 citations · View on PubMed ↗

HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis.

This individual patient-level meta-analysis evaluated whether the HER2DX genomic test risk score predicts survival outcomes in early-stage HER2-positive breast cancer, integrating clinical and tumor biology stratification for patients with ERBB2 amplification. The study found that HER2DX risk scores were associated with survival outcomes, supporting the test’s ability to capture biological heterogeneity beyond standard clinical-pathological variables. Clinically, HER2DX may improve risk stratification and personalization of treatment decisions in early-stage HER2-positive disease.

Villacampa G, Pascual T, Tarantino P et al. · The Lancet. Oncology · (2025) · 14 citations · View on PubMed ↗

Noninvasive prognostic classification of ITH in HCC with multi-omics insights and therapeutic implications.

This multicenter study (851 patients from five centers) developed a noninvasive radiomics-based intratumoral heterogeneity (ITH) prognostic classification for hepatocellular carcinoma (HCC) using multi-sequence MRI to define radiomics ITH (RITH) phenotypes. The RITH phenotypes correlated with prognosis and pathological ITH, and integrated multi-omics analyses linked them to underlying molecular mechanisms. This provides a clinically actionable imaging biomarker framework to stratify HCC patients by ITH and potentially guide therapy selection.

Xie Y, Wang F, Wei J et al. · Science advances · (2025) · 16 citations · View on PubMed ↗ · Free PDF ↗

A novel glycolysis-related gene signature for predicting prognosis and immunotherapy efficacy in breast cancer.

This study developed and validated a glycolysis-related gene (GRG) signature to predict prognosis and immunotherapy efficacy in breast invasive carcinoma using TCGA-BRCA as a training set and GEO as a validation cohort. The authors identified a novel GRG-based prognostic model that stratified breast cancer patients by survival risk and was associated with differences in immunotherapy response. The work supports glycolysis gene profiling as a potential biomarker strategy to improve risk prediction and guide immunotherapy selection in heterogeneous breast cancer patients.

Huang R, Li Y, Lin K et al. · Frontiers in immunology · (2025) · 5 citations · View on PubMed ↗ · Free PDF ↗

Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair.

This study investigated how the extracellular matrix proteoglycan versican (Versican) regulates cardiomyocyte proliferation and cardiac repair, using neonatal and adult mouse models of myocardial injury (apical resection and myocardial infarction). The key finding was that Versican promotes cardiomyocyte proliferation and improves regenerative cardiac repair, with mechanistic links to injury-associated extracellular matrix changes. These results are significant because they identify a potential molecular lever to enhance heart regeneration beyond the limited neonatal window.

Feng J, Li Y, Li Y et al. · Circulation · (2024) · 107 citations · View on PubMed ↗

ANGPTL2+cancer-associated fibroblasts and SPP1+macrophages are metastasis accelerators of colorectal cancer.

This study analyzed colorectal cancer metastasis mechanisms by integrating bulk RNA-seq and clinicopathologic data from TCGA/GEO with single-cell RNA-seq analyses to identify metastasis-accelerating immune/stromal populations. The key finding was that ANGPTL2+ cancer-associated fibroblasts and SPP1+ macrophages act as metastasis accelerators of colorectal cancer, particularly for liver metastasis, and represent potential therapeutic targets. This is clinically relevant because targeting these pro-metastatic microenvironment cell states could improve outcomes for CRC patients at high risk of liver spread.

Liu X, Qin J, Nie J et al. · Frontiers in immunology · (2023) · 58 citations · View on PubMed ↗ · Free PDF ↗

---

Immunotherapy biomarkers & resistance mechanisms

Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer.

This study analyzed paired tumor-infiltrating and circulating CD8+ tumor-reactive T cells in non-small cell lung cancer (NSCLC) patients using single-cell RNA sequencing and T cell receptor (TCR) sequencing. It found that the phenotype of circulating tumor-reactive T cells—marked by specific surface markers such as CD49a, CD49b, and HLA-DR—predicts response to immune checkpoint inhibitors. This provides a potential blood-based biomarker strategy to stratify NSCLC patients for immunotherapy.

Ito K, Iida K, Hirano T et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

This study examined how SLC2A1+ tumor-associated macrophages (TAMs) spatially regulate CD8+ T cell function and drive resistance to immunotherapy in NSCLC using human biopsies and murine tumor models. It found that TAM-specific deletion of Slc2a1 enhances the spatial homogeneity and effector function of intratumoral CD8+ T cells and improves αPD-L1 efficacy, whereas tumor-cell Slc2a1 knockdown did not replicate the benefit. This supports targeting the TAM SLC2A1 axis as a strategy to overcome checkpoint blockade resistance.

Wang L, Chu H, Chen D et al. · Nature cell biology · (2026) · 2 citations · View on PubMed ↗ · Free PDF ↗

Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?

This 2024 Clinical and Experimental Immunology article reviewed strategies to disrupt B and T-cell collaboration in autoimmune disease, contrasting B-cell depletion approaches (e.g., anti-CD20 monoclonal antibodies such as rituximab, ocrelizumab, and ofatumumab) with T-cell engager concepts and CAR T-cell therapy. It emphasizes that incomplete B-cell depletion can leave specific B-cell/plasma cell populations (including IgD-CD27+ switched memory B cells and CD19+CD20− B cells) that may contribute to refractory disease. Scientifically, the review frames how different immunotherapies may differentially control pathogenic B-cell subsets and informs future combination or next-generation cellular strategies.

Shah K, Leandro M, Cragg M et al. · Clinical and experimental immunology · (2024) · 31 citations · View on PubMed ↗ · Free PDF ↗

---

Cancer cell survival pathways (autophagy, ferroptosis, senescence, metabolism)

SIRT3 deacetylates STEAP4 to modulate cuproptosis sensitivity via mitochondrial metabolic reprogramming in HBV-related HCC.

The authors studied HBV-related hepatocellular carcinoma (HCC) to determine how SIRT3 regulates STEAP4 and thereby modulates sensitivity to cuproptosis through mitochondrial metabolic reprogramming. They found that HBV X protein (HBx) drives cuproptosis evasion by downregulating STEAP4, and that SIRT3 deacetylates STEAP4 to alter mitochondrial metabolism and cuproptosis susceptibility. This links an HBx–SIRT3–STEAP4 axis to copper-dependent cell death vulnerability, suggesting potential biomarkers or therapeutic strategies for HBV-driven HCC.

Du ZB, Wu XM, Lei JM et al. · Cell death and differentiation · (2026) · View on PubMed ↗

Structural basis for the recruitment and selective phosphorylation of Akt by mTORC2.

This structural biology study determined the mechanism by which mTORC2 selectively recruits and phosphorylates Akt by trapping the mTORC2–Akt complex using semisynthetic probes. The key finding was a structural basis for how mTORC2 recognizes Akt and achieves substrate selectivity for Akt (and PKC) rather than closely related mTORC1 substrates. This advances mechanistic understanding of a central signaling pathway frequently deregulated in cancer and diabetes.

Taylor MS, Chen M, Hancock M et al. · Science (New York, N.Y.) · (2026) · 5 citations · View on PubMed ↗ · Free PDF ↗

Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells.

This study examined venetoclax (Ven)-resistant acute myeloid leukemia (AML) stem cells (LSCs) and how they rewire metabolism and ribosome biogenesis to survive OXPHOS inhibition. The key finding is that abundant de novo guanine nucleotide biosynthesis sustains ribosome biogenesis by suppressing the impaired ribosome biogenesis checkpoint (IRBC), leading to TP53 destabilization and persistent MYC expression during glycolytic reprogramming. Clinically, targeting guanine nucleotide metabolism or the ribosome biogenesis checkpoint could help overcome Ven resistance in AML.

Kawano G, Ikeda R, Ishihara D et al. · Blood · (2026) · 1 citations · View on PubMed ↗ · Free PDF ↗

Cellular senescence-associated gene IFI16 promotes HMOX1-dependent evasion of ferroptosis and radioresistance in glioblastoma.

This mechanistic study investigated how the cellular senescence-associated gene IFI16 regulates HMOX1-dependent ferroptosis evasion and radioresistance in glioblastoma using a radioresistant GBM cell model generated by repeated irradiation. The authors found that IFI16 promotes radioresistance by activating HMOX1 transcription, which reduces lipid peroxidation, ROS production, and intracellular Fe2+ after irradiation. These findings are significant because they identify the IFI16–HMOX1 axis as a potential therapeutic target to sensitize glioblastoma to radiotherapy via ferroptosis modulation.

Zhou Y, Zeng L, Cai L et al. · Nature communications · (2025) · 32 citations · View on PubMed ↗ · Free PDF ↗

Autophagy in cancer development, immune evasion, and drug resistance.

This review article synthesized evidence on how macroautophagy/autophagy contributes to cancer development, immune evasion, and drug resistance, emphasizing context-dependent roles across tumor stages. It concludes that autophagy can switch from tumor-suppressive effects in early disease to tumor-promoting functions later, influenced by genetic and environmental factors. Understanding these stage- and pathway-specific mechanisms is clinically important for designing autophagy-targeted cancer therapies and overcoming drug resistance.

Niu X, You Q, Hou K et al. · Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · (2025) · 125 citations · View on PubMed ↗ · Free PDF ↗

---

Clinical oncology trials & treatment sequencing

PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-center, single-arm, phase 2 trial.

This multicenter, single-arm phase 2 trial (CAP 06; NCT04609176) studied first-line camrelizumab (PD-1 antibody) plus apatinib and SOX (S-1 and oxaliplatin) in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma. The trial assessed antitumor activity, safety, and biomarkers, with maintenance camrelizumab plus apatinib after initial therapy (primary endpoint and results truncated in the abstract). Clinically, it targets a rare, highly angiogenic and immunosuppressive subtype with a combined immunotherapy–antiangiogenic regimen to improve response rates and outcomes.

Wang Y, Lu J, Chong X et al. · Signal transduction and targeted therapy · (2025) · 11 citations · View on PubMed ↗ · Free PDF ↗

Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.

This phase 3 randomized trial in newly diagnosed chronic myeloid leukemia compared asciminib (80 mg once daily; a BCR::ABL1 inhibitor targeting the ABL myristoyl pocket) versus an investigator-selected ATP-competitive TKI. Asciminib demonstrated efficacy and safety outcomes intended to be superior or at least favorable relative to standard frontline TKIs in this treatment-naïve population. Clinically, it supports asciminib as a potential frontline option for CML patients with a distinct mechanism from ATP-competitive TKIs.

Hochhaus A, Wang J, Kim DW et al. · The New England journal of medicine · (2024) · 130 citations · View on PubMed ↗

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.

This phase 2 umbrella trial studied biomarker-directed targeted therapy combined with durvalumab (anti–PD-L1) in advanced non-small-cell lung cancer (NSCLC), particularly for tumors lacking currently targetable molecular alterations. The trial is designed to address resistance to immune checkpoint blockade by matching therapies to resistance mechanisms such as DNA damage response/repair defects, STK11/LKB1 alterations, antigen-presentation pathway changes, and immunosuppressive tumor microenvironment features. The study is clinically significant because it tests whether biomarker-guided combination strategies can improve durability of benefit beyond standard anti–PD-(L)1–based care.

Besse B, Pons-Tostivint E, Park K et al. · Nature medicine · (2024) · 111 citations · View on PubMed ↗ · Free PDF ↗

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

This multicentre, randomized phase 2 trial (NORPACT-1) studied neoadjuvant FOLFIRINOX versus upfront surgery in adults with resectable pancreatic head ductal adenocarcinoma undergoing resection. The trial was designed to compare efficacy and safety of neoadjuvant modified fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) against the standard upfront surgical approach. The results are clinically important because they test whether preoperative systemic therapy improves outcomes in resectable pancreatic cancer, potentially changing standard treatment sequencing.

Labori KJ, Bratlie SO, Andersson B et al. · The lancet. Gastroenterology & hepatology · (2024) · 196 citations · View on PubMed ↗

---

Neurology: CNS disorders & neurotherapeutics

Large-scale single-neuron recording in the human cortex using an ultra-flexible electrode array.

The authors developed and tested an ultra-flexible implantable neural electrode array (uFINE) for large-scale single-neuron recordings during intraoperative procedures in human patients. The uFINE array enabled reliable, high-density single-unit recordings while maintaining mechanical integrity throughout surgery. This advances translational neurotechnology for clinical and research applications requiring stable, high-resolution human cortical recordings.

Wu S, Yan Z, Kong C et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

Comparative effectiveness of atogepant and rimegepant for migraine prevention in Japanese patients: an anchored matching-adjusted indirect comparison.

This anchored matching-adjusted indirect comparison compared atogepant versus rimegepant for migraine prevention in Japanese patients using data from three placebo-controlled trials (RELEASE and PROGRESS for atogepant; BHV3000-309 for rimegepant). The key finding was the comparative effectiveness on monthly migraine days and acute medication use days, along with differences in quality-of-life and disability outcomes derived from the MAIC framework. Clinically, it helps inform preventive treatment selection in Japanese practice when head-to-head trial data are unavailable.

Takizawa T, Ahmadyar G, Tyas E et al. · Expert review of neurotherapeutics · (2026) · View on PubMed ↗

Diagnostic accuracy of the Gold Coast Criteria for amyotrophic lateral sclerosis: a systematic review and meta-analysis.

This systematic review and meta-analysis compared the diagnostic accuracy of the Gold Coast Criteria (GCC) for amyotrophic lateral sclerosis (ALS) against the Revised El Escorial Criteria (rEEC) and Awaji Criteria (AC) in suspected ALS. The key finding is the pooled sensitivity and specificity estimates derived from studies applying these criteria (with quality assessed by QUADAS-2 and STARD), including sensitivity analyses that excluded the largest imputed-data study. Clinically, clarifying which criteria perform best supports more accurate ALS diagnosis and earlier appropriate management.

von Quednow E, Husain N, Łajczak P et al. · Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · (2025) · 2 citations · View on PubMed ↗

Diabetic retinal disease.

This primer reviewed diabetic retinal disease (DRD), reframing it as a whole-retina disorder affecting microvasculature plus neurons and glia, rather than only diabetic retinopathy. The key finding is that ongoing preclinical and clinical efforts are integrating retinal signs with visual acuity and patient-reported vision-related quality of life, alongside systemic health and biochemical milieu in people with diabetes. Scientifically, this supports more comprehensive biomarkers and trial endpoints to better predict and manage vision outcomes in DRD.

Sivaprasad S, Wong TY, Gardner TW et al. · Nature reviews. Disease primers · (2025) · 22 citations · View on PubMed ↗

Fibroblast bioelectric signaling drives hair growth.

This study examined how fibroblast bioelectric signaling controls hair growth by analyzing congenital generalized hypertrichosis terminalis (CGHT) genetics and using mouse genetics to test functional mechanisms in dermal fibroblasts. Chromatin disruption of topologically associating domains (TADs) upregulated the potassium channel KCNJ2, and KCNJ2-mediated membrane hyperpolarization enhanced dermal fibroblast Wnt signaling response to promote hair growth. These results identify KCNJ2-driven fibroblast electrical signaling as a potential therapeutic axis for stimulating hair growth.

Chen D, Yu Z, Wu W et al. · Cell · (2025) · 11 citations · View on PubMed ↗

Tofersen: A Review in Amyotrophic Lateral Sclerosis Associated with SOD1 Mutations.

This review summarized evidence for tofersen (QALSODY®), an antisense oligonucleotide that induces SOD1 mRNA degradation, in amyotrophic lateral sclerosis (ALS) associated with SOD1 mutations. It reports that in the 28-week placebo-controlled phase III VALOR trial, intrathecal tofersen reduced plasma neurofilament proteins and decreased total SOD1 protein in cerebrospinal fluid, with sustained biomarker effects in a long-term open-label extension. The review emphasizes tofersen’s disease-targeting mechanism and biomarker impact, while noting that functional decline benefits were not clearly significant in the available results.

McGuigan A, Blair HA · CNS drugs · (2025) · 10 citations · View on PubMed ↗

Catalytic neural stem cell exosomes for multi-stage targeting and synergistical therapy of retinal ischemia-reperfusion injury.

This study engineered catalytic neural stem cell exosomes decorated with polylysine (K10) and expressing catalase (CataKNexo) to target the outer nuclear layer in retinal ischemia-reperfusion injury (RIRI). In vitro retinal models showed that CataKNexo reached the ONL and provided synergistic antioxidant and neuroprotective effects by countering H2O2-mediated oxidative stress. The work supports a targeted exosome platform that could translate into combination antioxidant/neuroprotection strategies for RIRI.

Yang W, Wang X, Zheng D et al. · Cell reports. Medicine · (2025) · 7 citations · View on PubMed ↗ · Free PDF ↗

Tofersen for SOD1 amyotrophic lateral sclerosis: a systematic review and meta-analysis.

This systematic review and meta-analysis synthesized clinical evidence on tofersen, an antisense oligonucleotide targeting the SOD1 gene, for safety and efficacy in adults with SOD1-mutant amyotrophic lateral sclerosis (ALS). Across 12 included studies totaling 195 treated patients, the authors summarized tofersen outcomes using random-effects meta-analysis methods. The findings are significant because they consolidate the evidence base supporting tofersen’s clinical use in SOD1-related ALS and clarify its overall safety/efficacy profile.

Hamad AA, Alkhawaldeh IM, Nashwan AJ et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · (2025) · 24 citations · View on PubMed ↗ · Free PDF ↗

Red and Green LED Light Therapy: A Comparative Study in Androgenetic Alopecia.

This comparative clinical study evaluated red versus green LED light therapy for androgenetic alopecia (AGA) using an LED helmet delivering 40 J/cm² over 20 minutes to the frontal scalp. The study compared clinical photography, physician 7-point evaluations, patient satisfaction, and other measures between red and green light halves of the scalp. Demonstrating differential efficacy between red and green LLLT could refine nonpharmacologic AGA treatment choices beyond standard options like minoxidil and finasteride.

Tantiyavarong J, Charoensuksira S, Meephansan J et al. · Photodermatology, photoimmunology & photomedicine · (2024) · 8 citations · View on PubMed ↗ · Free PDF ↗

Tofersen for SOD1 ALS.

This article reviewed the therapeutic rationale and clinical evidence for tofersen in SOD1-associated ALS, focusing on antisense oligonucleotide “knock-down” of SOD1 mRNA. It notes that while a Phase III trial failed to meet its primary endpoint, open-label extension data suggest tofersen may slow progression in SOD1 ALS. The discussion supports continued evaluation of tofersen in genetically defined ALS populations where targeted SOD1 reduction is biologically plausible.

Everett WH, Bucelli RC · Neurodegenerative disease management · (2024) · 24 citations · View on PubMed ↗ · Free PDF ↗

Six types of loves differentially recruit reward and social cognition brain areas.

This fMRI study in humans induced feelings of love using short stories and compared brain activity across six love objects: romantic partner, children, friends, strangers, pets, and nature. Neural recruitment during love differed by object, with distinct patterns across reward and social cognition brain areas. These findings clarify that “love” is not a single neural state and may help refine mechanistic models of pair bonding and other attachment-related behaviors.

Rinne P, Lahnakoski JM, Saarimäki H et al. · Cerebral cortex (New York, N.Y. : 1991) · (2024) · 13 citations · View on PubMed ↗ · Free PDF ↗

Low-intensity transcranial focused ultrasound suppresses pain by modulating pain-processing brain circuits.

This in vivo mouse study tested low-intensity transcranial focused ultrasound (tFUS) to suppress pain by targeting pain-processing brain circuits using a custom 128-element ultrasound transducer with dynamic focus steering. Focused ultrasound stimulation altered pain-associated behaviors after a single session by modulating neural pain-processing circuits. The work is significant as a nonpharmacological neuromodulation approach that could reduce reliance on opioid-based chronic pain treatments.

Kim MG, Yu K, Yeh CY et al. · Blood · (2024) · 29 citations · View on PubMed ↗ · Free PDF ↗

Transcutaneous Electrical Stimulation for Neurogenic Bladder After Spinal Cord Injury: A Systematic Review and Meta-Analysis.

This systematic review and meta-analysis studied transcutaneous electrical nerve stimulation (TENS) for neurogenic bladder after spinal cord injury by pooling randomized controlled trials up to December 31, 2022. The key finding was that TENS improved primary cystometric outcomes—maximum cystometric capacity (MCC) and residual urine volume (RUV)—with additional effects assessed on detrusor pressure, flow rate, and bladder diary measures. Clinically, the results support TENS as a potentially beneficial noninvasive intervention for bladder dysfunction in SCI, while also quantifying evidence strength across trials.

Jiang Y, Li X, Guo S et al. · Neuromodulation : journal of the International Neuromodulation Society · (2024) · 11 citations · View on PubMed ↗

---

Cardiology: arrhythmia & electrophysiology interventions

Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects.

This review summarized 10 novel key aspects of the 2024 ESC/EACTS atrial fibrillation management guidelines, focusing on practical implications for patient care. It highlighted the AF-CARE framework—comorbidity/risk factor management, stroke/thromboembolism avoidance, symptom reduction via rate/rhythm control, and dynamic reassessment—as a structural approach to improve outcomes. The clinical significance is that it translates guideline updates into an actionable framework for clinicians managing atrial fibrillation.

Rienstra M, Tzeis S, Bunting KV et al. · Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · (2024) · 86 citations · View on PubMed ↗ · Free PDF ↗

Cardioneuroablation for the treatment of reflex syncope and functional bradyarrhythmias: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS) and the Latin American Heart Rhythm Society (LAHRS).

This 2024 EHRA/ESC, HRS, APHRS, and LAHRS scientific statement reviewed evidence for cardioneuroablation in patients with reflex syncope and functional vagally mediated bradyarrhythmias (e.g., vagally induced sinus bradycardia-arrest or atrioventricular block). It concludes that appropriate patient selection and procedural technique are prerequisites for safe and effective use as an alternative to cardiac pacing in selected cases. The statement is significant for harmonizing practice and improving safety in a growing interventional therapy area.

Aksu T, Brignole M, Calo L et al. · Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · (2024) · 61 citations · View on PubMed ↗ · Free PDF ↗

Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study.

This prospective randomized controlled study evaluated whether high-power short-duration (HPSD) atrial fibrillation ablation using the Smart Touch Surround Flow (STSF) catheter reduces silent cerebral embolism (SCE) compared with conventional ablation using the Smart Touch (ST) catheter. It randomized 100 AF patients 1:1 to HPSD with STSF versus conventional ST approaches and assessed SCE incidence as the primary outcome. The significance is that it tests a procedural parameter/catheter strategy to reduce subclinical brain embolic risk during AF ablation, informing safer electrophysiology practice.

Chen WJ, Gan CX, Cai YW et al. · BMC medicine · (2023) · 10 citations · View on PubMed ↗ · Free PDF ↗

---

Cardiology: screening & cardiovascular risk prediction

Cardiac Screening for Conditions Associated With Sudden Cardiac Death: Yield, Interventions, and SCA/SCD Incidence in 104,369 Young Individuals.

This study evaluated population cardiac screening (questionnaire plus electrocardiogram) in 104,369 young individuals aged 14–35 years in the general population. The key findings were the diagnostic yield of screening, the rate of new cardiac diagnoses after initial clearance, and the incidence of sudden cardiac arrest and sudden cardiac death following a single screening. These results inform the clinical value and downstream impact of broad ECG-based screening programs beyond young athletes.

MacLachlan H, Bhatia R, Raju H et al. · Journal of the American College of Cardiology · (2026) · 1 citations · View on PubMed ↗

Organ-specific proteomic aging clocks predict disease and longevity across diverse populations.

This study developed organismal and organ-specific proteomic aging clocks using plasma proteomics and machine learning in UK Biobank participants (n=43,616) and validated them in independent cohorts from China (n=3,977) and the USA (n=800). It found that accelerated organ aging predicted disease onset, progression, and mortality beyond clinical and genetic risk factors, with brain aging most strongly linked to mortality, and it associated brain aging with lifestyle and genes including GABBR1 and ECM1. Scientifically, these proteomic clocks provide cross-population tools to quantify biological aging and identify organ-specific risk drivers for age-related disease and longevity.

Wang Y, Xiao S, Liu B et al. · Nature aging · (2026) · 7 citations · View on PubMed ↗ · Free PDF ↗

Blood plasma proteome-wide association study implicates novel proteins in the pathogenesis of multiple cardiovascular diseases.

This study performed a proteome-wide association study (PWAS) using plasma proteomics from 53,022 participants in the UK Biobank Pharma Proteomics Project (UKB-PPP) to identify proteins implicated in 26 cardiovascular diseases (CVDs) using SNP–protein weights integrated with GWAS summary statistics. The analysis implicated novel proteins across cardiac, venous, and cerebrovascular disease categories. The results provide new candidate protein targets for CVD pathogenesis and potential therapeutic development using genetic-proteomic evidence.

Wang JH, Dong SS, Huang W et al. · Cardiovascular diabetology · (2025) · 4 citations · View on PubMed ↗ · Free PDF ↗

---

Nephrology & kidney disease (risk, biomarkers, glomerular disorders)

Glucagon-like Peptide-1 Receptor Agonist Impact on Chronic Ocular Disease Including Age-Related Macular Degeneration.

This retrospective cohort study used US electronic health records to evaluate whether glucagon-like peptide-1 receptor agonists (GLP-1RAs) affect the risk of chronic ocular diseases, including age-related macular degeneration, in patients older than 60 years. After propensity score matching (1:1) against comparator medication groups (metformin, insulin, statin, or aspirin), GLP-1RA exposure was associated with altered risk of age-related ocular outcomes compared with other medication users. The clinical significance is that it provides real-world evidence on whether GLP-1RAs may confer ocular protection or risk modification relevant to older adults at high baseline risk.

Allan KC, Joo JH, Kim S et al. · Ophthalmology · (2025) · 32 citations · View on PubMed ↗ · Free PDF ↗

Large-Scale Proteomics Improve Prediction of Chronic Kidney Disease in People With Diabetes.

This UK Biobank cohort study (n=2,094 adults with diabetes, no baseline CKD) used plasma proteomics (~3,000 proteins) to build and validate an 11-protein CKD protein risk score and compared it with the CKD Prediction Consortium clinical model and a CKD polygenic risk score. The protein risk score improved prediction of incident chronic kidney disease over long follow-up (median 12.1 years). Scientifically, it supports proteomics-derived risk stratification for diabetic CKD and may enable earlier identification of high-risk patients beyond clinical and genetic scores.

Ye Z, Zhang Y, Zhang Y et al. · Diabetes care · (2024) · 24 citations · View on PubMed ↗

Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy.

This retrospective observational database study emulating a target trial in adults with type 2 diabetes and moderate cardiovascular disease risk compared initiation of GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, and sulfonylureas for risk of sight-threatening diabetic retinopathy. It assessed whether the glucose-lowering agent class influenced development of advanced retinal complications in patients without baseline advanced diabetic retinal disease. The results are significant for treatment selection in T2D by linking medication choice to ophthalmic risk.

Barkmeier AJ, Herrin J, Swarna KS et al. · Ophthalmology. Retina · (2024) · 17 citations · View on PubMed ↗ · Free PDF ↗

A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy.

This phase 2b randomized, double-blind, placebo-controlled trial studied atacicept (dual BAFF/APRIL fusion protein) in 116 biopsy-proven IgA nephropathy patients, comparing atacicept 150 mg, 75 mg, or 25 mg versus placebo once weekly for up to 36 weeks. Atacicept was evaluated by changes in urine protein-to-creatinine ratio from 24-hour urine collections at weeks 24 and 36 as primary and key secondary endpoints. The findings are scientifically and clinically important because they test a B-cell–targeted mechanism to reduce proteinuria in IgA nephropathy, potentially informing future disease-modifying therapy.

Lafayette R, Barbour S, Israni R et al. · Kidney international · (2024) · 107 citations · View on PubMed ↗ · Free PDF ↗

---

Endocrinology & metabolic disease (diabetes, obesity, diet, microbiome)

Oat β-glucan reshapes gut microbiota to enhance glucose homeostasis via coordinated modulation of bile acid conjugation and succinate-dependent intestinal gluconeogenesis.

This study examined whether oat β-glucan improves glucose homeostasis by reshaping gut microbiota and altering bile acid conjugation and succinate-dependent intestinal gluconeogenesis in obese mice. Oat β-glucan improved glucose intolerance and insulin resistance, increased GLP-1 secretion, and promoted secondary bile acids (including lithocholic acid and deoxycholic acid) alongside microbiome shifts toward taxa such as Faecalibaculum, Muribaculaceae (norank_f), Bifidobacterium, and Akkermansia. These results support a microbiota–bile acid–gluconeogenesis mechanism for oat β-glucan’s antidiabetic effects.

Meng Y, Li S, Zhou K et al. · Food chemistry · (2026) · View on PubMed ↗

Vitamin C conveys geroprotection on primate ovaries.

This study tested whether oral vitamin C can mitigate ovarian aging in primates by measuring changes in aging biomarkers and cellular “biological age” using a single-cell transcriptomic clock. The key finding is that vitamin C reduces oxidative stress and follicular depletion and lowers the transcriptomic biological age of oocytes and somatic cells, with partial mediation through the NRF2 pathway that alleviates ovarian cell senescence. Scientifically and clinically, these results support vitamin C as a single-agent geroprotective intervention with a defined molecular pathway in primate ovarian aging.

Jing Y, Lu H, Li J et al. · Cell stem cell · (2025) · 6 citations · View on PubMed ↗

Alpha-Ketoisocaproate Attenuates Muscle Atrophy in Cancer Cachexia Models.

This study tested whether α-ketoisocaproate (KIC), a metabolite of L-leucine, attenuates muscle atrophy in cancer cachexia by targeting myostatin using BALB/c mice and C2C12 myotubes in C26- and 4T1-induced cachexia models. KIC treatment reduced cancer cachexia–associated muscle wasting and modulated the myostatin pathway. The findings support KIC as a candidate metabolic intervention for cancer-associated muscle loss with a defined molecular target (myostatin).

Lim P, Woo SW, Han J et al. · Journal of cachexia, sarcopenia and muscle · (2025) · 1 citations · View on PubMed ↗ · Free PDF ↗

hUC-MSCs and derived exosomes attenuate DEX-induced muscle atrophy through modulation of estrogen signaling pathway.

This preclinical study evaluated whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) and their derived exosomes (MSC-Exos) attenuate dexamethasone (DEX)-induced muscle atrophy by modulating the estrogen signaling pathway. The authors report that both hUC-MSCs and MSC-Exos improved muscle atrophy phenotypes and shifted estrogen-pathway signaling toward a protective profile. These data suggest MSC-Exos may be a cell-free regenerative strategy for sarcopenia/atrophy by engaging estrogen-mediated mechanisms.

Li N, Liu X, Wang Q et al. · Stem cell research & therapy · (2025) · 4 citations · View on PubMed ↗ · Free PDF ↗

Antiosteoporosis medication in patients with posterior spine fusion: a systematic review and meta-analysis.

This systematic review and meta-analysis compared osteoporosis medications—teriparatide, bisphosphonates, denosumab, and romosozumab—in patients with low bone mineral density undergoing posterior spine fusion. It aimed to determine which perioperative drug strategy best improves fusion rates and reduces complications such as pseudarthrosis and screw loosening. The clinical significance is that it seeks to inform evidence-based perioperative pharmacologic choice to optimize surgical outcomes in this high-risk population.

Jin H, Jin H, Suk KS et al. · The spine journal : official journal of the North American Spine Society · (2025) · 7 citations · View on PubMed ↗

Intermittent fasting boosts sexual behavior by limiting the central availability of tryptophan and serotonin.

This study tested intermittent fasting (IF) in male C57BL/6J mice to determine how it affects age-related declines in reproductive behavior and success. IF preserved reproductive success in aged mice by improving mating behavior through limiting central availability of tryptophan and thereby reducing serotonergic inhibition. The findings suggest a mechanistic link between dietary timing, tryptophan/serotonin signaling, and behavioral fertility outcomes in aging.

Xie K, Wang C, Scifo E et al. · Cell metabolism · (2025) · 10 citations · View on PubMed ↗ · Free PDF ↗

Skeletal Muscle Stem Cells and the Microenvironment Regulation in Sarcopenia:A Review.

This review article summarized current evidence on skeletal muscle stem cells (satellite cells) and how the muscle microenvironment regulates their function in sarcopenia. It concluded that age-related changes in the microenvironment can impair satellite cell activity and thereby contribute to loss of muscle mass and function. The scientific significance is that it frames sarcopenia as a stem-cell–microenvironment problem, highlighting potential targets for regenerative or microenvironment-modifying therapies.

Gao T, Zhang Y, Zhang D et al. · Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae · (2024) · 1 citations · View on PubMed ↗

Colon-targeted engineered postbiotics nanoparticles alleviate osteoporosis through the gut-bone axis.

This preclinical study engineered colon-targeted postbiotics nanoparticles to deliver butyric acid to the colorectal site and tested their effects on osteoporosis via the gut-bone axis. The authors reported that polyvinyl butyrate nanoparticles with shellac resin achieved sustained butyric acid release, suppressing macrophage inflammatory activation, improving redox balance, and shifting gut microbial composition to mitigate bone loss. The significance is that it provides a targeted delivery platform that may improve the efficacy and safety of butyrate-based postbiotic interventions for osteoporosis.

Yu T, Bai R, Wang Z et al. · Nature communications · (2024) · 34 citations · View on PubMed ↗ · Free PDF ↗

Berberine and magnolol exert cooperative effects on ulcerative colitis in mice by self-assembling into carrier-free nanostructures.

This preclinical mouse study tested whether berberine (BBR) and magnolol (MAG) cooperate to treat ulcerative colitis (UC) by self-assembling into carrier-free nanostructures. The compounds formed nanostructures in aqueous solution via charge interactions and π–π stacking, and the study reports cooperative anti-UC effects in mice (with pharmacokinetic characterization described in the abstract). These findings suggest a novel phytochemical nanomedicine strategy that could improve UC drug delivery and efficacy without conventional carriers.

Xu Y, Chen Z, Hao W et al. · Journal of nanobiotechnology · (2024) · 56 citations · View on PubMed ↗ · Free PDF ↗

Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis.

This Science Advances study developed an oral sodium alginate microsphere formulation containing M2 macrophage membrane–coated Janus nanomotors (Motor@M2M) for targeted ulcerative colitis therapy. The M2 macrophage mimetic coating enhanced targeting to inflammatory tissues and acted as a decoy to neutralize inflammatory cytokines while the microspheres protected the nanomotors in gastric conditions and enabled controlled release. This is clinically relevant because it addresses UC barriers (mucus penetration, ROS/cytokine burden) using a macrophage-mimetic, orally deliverable nanotherapy.

Luo R, Liu J, Cheng Q et al. · Science advances · (2024) · 112 citations · View on PubMed ↗ · Free PDF ↗

Coordinated action of a gut-liver pathway drives alcohol detoxification and consumption.

This Nature Metabolism study investigated how a liver–gut pathway coordinates systemic acetaldehyde (AcH) clearance and voluntary alcohol drinking, focusing on aldehyde dehydrogenase 2 (ALDH2)–dependent detoxification. It found that liver alone explains only part of systemic AcH clearance and that gut excretion of liver-generated AcH synergistically drives both AcH clearance and alcohol consumption behavior. The findings are significant for alcohol use disorder biology because they identify a gut-liver axis as a potential therapeutic target beyond hepatic ALDH2.

Fu Y, Mackowiak B, Lin YH et al. · Nature metabolism · (2024) · 52 citations · View on PubMed ↗ · Free PDF ↗

Comparative Evaluation of a Low-Carbohydrate Diet and a Mediterranean Diet in Overweight/Obese Patients with Type 2 Diabetes Mellitus: A 16-Week Intervention Study.

This 16-week intervention study compared a low-carbohydrate diet (LCD; <130 g/day) versus a Mediterranean diet in overweight/obese patients with type 2 diabetes mellitus. The abstract indicates the study was designed to evaluate differential metabolic and clinical effects of these dietary patterns as nutritional therapy for T2DM and obesity. The significance is that it provides comparative evidence on diet composition strategies that could inform personalized dietary management for glycemic control and weight-related outcomes.

Currenti W, Losavio F, Quiete S et al. · Nutrients · (2023) · 18 citations · View on PubMed ↗ · Free PDF ↗

---

Women’s health & reproductive medicine (PCOS, fertility, pregnancy, implantation, cancers)

Male germ cell-specific deletion of Eif5 causes the apoptosis of mouse progenitor spermatogonia by excessive endoplasmic reticulum stress and defective DNA repair.

Researchers generated male germ cell-specific Eif5 conditional knockout mice by crossing Eif5 fl/fl with Stra8-Cre to determine how loss of eukaryotic translation initiation factor 5 (eIF5) affects spermatogenesis. Eif5 deletion caused apoptosis of progenitor spermatogonia driven by excessive endoplasmic reticulum (ER) stress and impaired DNA repair, reducing SOX3+ progenitor spermatogonia and Kit+ germ cell populations. The work identifies eIF5 as a critical regulator of germ cell survival and genome maintenance, providing mechanistic insight relevant to idiopathic non-obstructive azoospermia (iNOA).

Wei H, Huang Y, Wang W et al. · Zoological research · (2026) · View on PubMed ↗ · Free PDF ↗

PGC-derived migrasomes couple PGC proliferation with migration.

Using zebrafish primordial germ cells (PGCs), the study investigated how migrasomes coordinate PGC proliferation with migration, focusing on tspan7-dependent migrasome biogenesis and delivery of the growth factor GDF3. Migrasomes formed at retraction fibers via tspan7-dependent mechanisms and delivered GDF3 to neighboring PGCs through contact-dependent interactions, activating the TGF-β receptor acvr1ba to drive proliferation. The findings reveal a mechanism that couples mitogenic signaling to migration to ensure germline expansion during development.

Liu B, Jiang Z, Song W et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

A clinical review of cervical cancer.

This clinical review summarized the epidemiology, risk factors, disparities, and care considerations for cervical cancer across global and U.S. contexts. It highlighted that incidence and mortality are disproportionately higher for Black, Latina, Hispanic, American Indian, and Alaska Native females, with the greatest burden in lower-income countries. The review underscores the need for equity-focused prevention, screening, and treatment strategies to reduce cervical cancer morbidity and deaths.

Pullen RL, Ritchie S · Nursing · (2026) · View on PubMed ↗

R-loops orchestrate RNAPII transcriptional reprogramming for the maternal-to-zygotic transition.

This study investigated how R-loops regulate RNA polymerase II (RNAPII) transcriptional reprogramming during the maternal-to-zygotic transition (MZT) in mammalian preimplantation embryos, focusing on CG density-dependent R-loop behavior. It found that loss of CG-poor R-loops causes severe MZT defects and promotes premature activation of major zygotic genome activation (ZGA) genes. These findings clarify a mechanistic role for R-loops in early embryonic gene regulation and developmental timing.

Li Y, Li Q, Wang X et al. · Cell research · (2026) · View on PubMed ↗ · Free PDF ↗

Cancer of the corpus uteri: A 2025 update.

This 2025 update article reviews endometrial (corpus uteri) cancer in terms of histopathology, staging, surgical and non-surgical management, follow-up, and treatment of recurrent disease. It highlights that endometrial cancer is heterogeneous, with increasing incidence and rising mortality. Clinically, the synthesis supports more tailored risk- and stage-informed care pathways and improved management strategies for recurrence.

Koskas M, Crosbie EJ, Fokdal L et al. · International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · (2025) · 18 citations · View on PubMed ↗ · Free PDF ↗

The modeling of human implantation and early placentation: achievements and perspectives.

This review article assessed achievements and future directions in modeling human implantation and early placentation using in vivo, ex vivo, and in vitro systems. It emphasized the ethical and biological challenges of studying maternal–fetal crosstalk in humans and compared the strengths and limitations of different model types, including cell line-derived approaches. The scientific significance is that it guides researchers toward more informative and translational models for peri-implantation biology and potential clinical interventions.

Dimova T, Alexandrova M, Vangelov I et al. · Human reproduction update · (2025) · 22 citations · View on PubMed ↗ · Free PDF ↗

Polycystic ovary syndrome.

This Nature Reviews Disease Primer reviewed polycystic ovary syndrome (PCOS) in women (and discusses possible relevance to men), focusing on diagnostic criteria and adolescent assessment. It highlights that adult PCOS diagnosis uses the International Evidence-based Guideline (two of three: clinical/biochemical hyperandrogenism, ovulatory dysfunction, and/or ovarian morphology or elevated anti-Müllerian hormone), whereas adolescent diagnosis omits ovarian morphology and anti-Müllerian hormone considerations. The review is clinically significant because it clarifies age-specific diagnostic standards for a condition affecting ~11–13% of women globally and aims to reduce under-recognition and misdiagnosis.

Stener-Victorin E, Teede H, Norman RJ et al. · Nature reviews. Disease primers · (2024) · 341 citations · View on PubMed ↗ · Free PDF ↗

Clinical Relevance of Vaginal and Endometrial Microbiome Investigation in Women with Repeated Implantation Failure and Recurrent Pregnancy Loss.

This review assessed the clinical relevance of vaginal and endometrial microbiome testing in women with repeated implantation failure and recurrent pregnancy loss. It summarizes evidence that Lactobacillus dominance is generally associated with reproductive tract eubiosis and better implantation outcomes, while vaginal/endometrial dysbiosis may promote local inflammation and pro-inflammatory cytokines that impair endometrial receptivity. The significance is that it frames microbiome investigation as a potential biomarker and mechanistic target to improve fertility outcomes in these challenging patient groups.

Gao X, Louwers YV, Laven JSE et al. · International journal of molecular sciences · (2024) · 69 citations · View on PubMed ↗ · Free PDF ↗

---

Infectious/inflammatory critical care (sepsis, VAP, thromboinflammation)

Akkermansia Muciniphila Alleviates Severe Acute Pancreatitis via Amuc1409-Ube2k-Foxp3 Axis in Regulatory T Cells.

This study examined how the gut commensal Akkermansia muciniphila regulates severe acute pancreatitis (SAP)–associated systemic inflammation and anti-inflammatory responses in patients and in Foxp3-DTR and IL-10 knockout mouse models. It found that Akkermansia abundance was reduced in acute pancreatitis patients and inversely associated with systemic inflammatory severity, and that A. muciniphila ameliorated SAP via an Amuc1409–Ube2k–Foxp3 axis in regulatory T cells. Scientifically, it identifies a microbiota–Treg signaling pathway that could be targeted to rebalance SIRS/CARS and improve SAP outcomes.

Xie J, Du L, Lu Y et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · (2025) · 9 citations · View on PubMed ↗ · Free PDF ↗

Platelet NLRP6 protects against microvascular thrombosis in sepsis.

This research investigated the role of nucleotide-oligomerization domain-like receptor family pyrin domain containing 6 (NLRP6) specifically in platelets during sepsis using platelet-specific NLRP6 knockout mice and the cecal ligation and puncture model. Platelet NLRP6 deletion increased mortality and worsened microvascular thrombosis in the lung and liver. The findings suggest platelet NLRP6 is protective in sepsis and could represent a therapeutic target to reduce thromboinflammation.

Jiang H, Chen S, Gui X et al. · Blood · (2025) · 14 citations · View on PubMed ↗ · Free PDF ↗

Incidence and risk factors of ventilator-associated pneumonia in the intensive care unit: a systematic review and meta-analysis.

This systematic review and meta-analysis estimated ventilator-associated pneumonia (VAP) incidence in ICU patients and identified risk factors and outcome impacts. It pooled ICU studies to quantify VAP occurrence and evaluate which patient or care-related factors were associated with VAP development. The results can guide prevention strategies and risk stratification to reduce morbidity and improve ICU outcomes.

Li W, Cai J, Ding L et al. · Journal of thoracic disease · (2024) · 21 citations · View on PubMed ↗ · Free PDF ↗

Review: sepsis guidelines and core measure bundles.

This 2024 review evaluated evolving sepsis screening tools and treatment protocol “core measure bundles” from major initiatives including the Surviving Sepsis Campaign, the Third International Consensus Definitions for Sepsis, and CMS measures. It summarizes how updated sepsis physiology understanding has changed recommended recognition and management steps to improve outcomes. Clinically, it supports standardized, timely sepsis care and highlights where guideline implementation may affect mortality, post-discharge quality of life, and readmission risk.

Desposito L, Bascara C · Postgraduate medicine · (2024) · 26 citations · View on PubMed ↗

---

Pulmonology & respiratory disease (lung cancer, IPF, smoke exposure)

Polyethylene terephthalate microplastics promote pulmonary fibrosis via AKT1, PIK3CD, and PIM1: A network toxicology and multi-omics analysis.

This study investigated whether polyethylene terephthalate microplastics (PET-MPs) exacerbate idiopathic pulmonary fibrosis (IPF) and delineated underlying mechanisms using network toxicology, molecular docking, Mendelian randomization, and single-cell sequencing, with toxicity prediction via ProTox 3.0. The authors report that PET-MP–driven IPF involves AKT1, PIK3CD, and PIM1 signaling pathways. These findings suggest PET-MPs may promote fibrotic lung remodeling through specific druggable molecular targets, supporting multi-omics/network approaches to environmental toxicant–disease causality in IPF.

Zhao W, Yang S, Hu S et al. · Ecotoxicology and environmental safety · (2025) · 7 citations · View on PubMed ↗ · Free PDF ↗

Association between second-hand smoke exposure and lung cancer risk in never-smokers: a systematic review and meta-analysis.

This systematic review and meta-analysis quantified the association between second-hand smoke (SHS) exposure and lung cancer risk specifically in never-smokers using epidemiologic studies. The analysis synthesized evidence that SHS exposure increases lung cancer risk in never-smokers. The results strengthen the public-health rationale for smoke-free policies and risk reduction efforts even among people who never actively smoke.

Possenti I, Romelli M, Carreras G et al. · European respiratory review : an official journal of the European Respiratory Society · (2024) · 30 citations · View on PubMed ↗ · Free PDF ↗

---

Environmental health & toxicology (microplastics, metals, additives, exposome)

Maltol induces diabetic fragility fractures by disrupting the balance of bone remodeling.

The study combined clinical metabolomics with in vivo and in vitro experiments to determine whether maltol, a widely used food additive, contributes to hyperglycemia-associated bone fragility and fragility fractures in type 2 diabetes. Maltol accumulation in femoral neck tissue and elevated circulating maltol correlated with higher fracture incidence, and mechanistically maltol inhibited osteoblast differentiation via Wnt/β-catenin while promoting osteoclast maturation via NF-κB signaling. These results identify maltol as a previously unrecognized dietary/metabolic risk factor and potential target for preventing diabetic fragility fractures.

Wang J, Wang Z, Feng J et al. · Cell metabolism · (2026) · View on PubMed ↗

The contribution of additives to microplastic aquatic toxicity - A testing approach with model additives on selected aquatic organisms.

This study developed and applied a testing methodology to disentangle particle-related effects from additive (chemical) contributions to microplastic aquatic toxicity using model additives and selected aquatic organisms. The key finding was that toxicity can be assessed by comparing additive-loaded microplastics, pristine additive-free microplastics, and additives alone, alongside characterization of additive release and aging effects. Scientifically, this improves causal attribution of microplastic harm and strengthens risk assessment frameworks for real-world exposures.

Perc V, Jemec Kokalj A, Drobne D et al. · Ecotoxicology and environmental safety · (2026) · 1 citations · View on PubMed ↗ · Free PDF ↗

The exposomal imprint on rosacea: More than skin deep.

This review synthesized evidence on how the exposome—combining intrinsic factors (genetics, immune dysregulation, microbiome, hormones, psychosocial stress) and extrinsic triggers (UV radiation, air pollution, diet, climate variability)—shapes rosacea pathogenesis. The key finding is that recent single-cell transcriptomics implicates fibroblasts as central mediators of inflammatory and vascular pathways in rosacea, alongside emerging roles for non-coding RNAs and RNA modifications. This “more than skin deep” framework highlights actionable research directions for targeting stromal and molecular drivers rather than focusing solely on surface inflammation.

Grafanaki K, Bakoli Sgourou D, Maniatis A et al. · Journal of the European Academy of Dermatology and Venereology : JEADV · (2026) · 3 citations · View on PubMed ↗ · Free PDF ↗

Bat genomes illuminate adaptations to viral tolerance and disease resistance.

This comparative genomics study analyzed bat genomes from the Bat1K project and broader mammalian datasets to identify genetic signatures underlying viral tolerance and disease resistance in bats. It found that immune-gene selection signatures are more prevalent in bats than in other mammalian orders, consistent with bats’ ability to harbor zoonotic viruses with limited immunopathology. The results are scientifically important because they pinpoint immune pathways that may explain bat viral tolerance and could inform strategies to enhance disease resistance in other species, including humans.

Morales AE, Dong Y, Brown T et al. · Nature · (2025) · 51 citations · View on PubMed ↗ · Free PDF ↗

Exposure to metal mixtures and adverse pregnancy and birth outcomes: A systematic review.

This systematic review evaluated evidence linking prenatal exposure to metal mixtures with adverse pregnancy and birth outcomes (eg, low birth weight, preterm birth, small for gestational age) across human studies. The key finding was that studies using real-life mixture exposure approaches are still limited, and the strength/consistency of associations remains variable with important research gaps compared with single-metal analyses. Clinically, the review highlights the need for improved mixture-based exposure assessment and study designs to better inform pregnancy and public-health policies.

Issah I, Duah MS, Arko-Mensah J et al. · The Science of the total environment · (2024) · 63 citations · View on PubMed ↗

---

Health systems, nursing, and clinical decision support (guidelines, culture, education, LLMs)

Modifiable risk factors and risk of schizophrenia and bipolar disorder across severities of genetic risk.

This study used UK Biobank participants to test whether the brain care score (BCS)—a 12-factor modifiable risk tool—predicts incident schizophrenia (SCZ) or bipolar disorder (BD) risk across strata of genetic liability measured by polygenic risk scores (PRS). Higher BCS was associated with lower SCZ/BD risk, with effects varying by level of PRS (gene–environment interaction/stratified patterns). These findings suggest that modifiable brain-health behaviors may reduce psychiatric risk even among individuals with high genetic predisposition.

Cui Y, Sun Y, Liu S et al. · Journal of affective disorders · (2026) · View on PubMed ↗

The global prevalence of eating disorders in children and young people: a systematic review and meta-analysis.

This systematic review and meta-analysis estimated the global prevalence of eating disorders in children and young people by pooling population-level prevalence studies from multiple databases (MEDLINE, EMBASE, PsycINFO, LILACS) covering 2013 to February 27, 2024. The key finding was a worldwide pooled prevalence estimate for eating disorders in youth, with quantified heterogeneity across studies. Clinically, these results help quantify the scale of the problem and support public health planning and resource allocation for early detection and treatment.

Faria C, Daneshi K, Baser A et al. · European child & adolescent psychiatry · (2026) · 3 citations · View on PubMed ↗ · Free PDF ↗

Neuraxial anesthesia and pain management for cesarean delivery.

This article reviewed neuraxial anesthesia and postoperative pain management strategies for cesarean delivery, focusing on how patient and obstetric factors influence anesthetic blockade and analgesia quality. The key finding is that anesthetic choice and perioperative coordination between obstetrics and anesthesia teams are crucial to tailor neuraxial techniques to the clinical scenario, especially for emergency cesarean delivery. The clinical significance is improved safety and more consistent, context-appropriate pain control for cesarean patients.

Landau R, Sultan P · American journal of obstetrics and gynecology · (2026) · 11 citations · View on PubMed ↗ · Free PDF ↗

Mapping early human blood cell differentiation using single-cell proteomics and transcriptomics.

This study mapped early human blood cell differentiation by generating single-cell proteomics using mass spectrometry (scp-MS) across an in vivo CD34+ hematopoietic stem/progenitor differentiation hierarchy (>2500 cells) and integrating it with single-cell RNA sequencing (scRNA-seq). Integration identified proteins important for stem cell function that were not reflected by corresponding mRNA transcripts. The work highlights that proteome-level single-cell profiling can reveal differentiation regulators missed by transcript-only approaches, improving mechanistic resolution of human hematopoiesis.

Furtwängler B, Üresin N, Richter S et al. · Science (New York, N.Y.) · (2025) · 17 citations · View on PubMed ↗

Medication Adherence in Hypertension: A Cluster Randomized Clinical Trial.

This cluster randomized clinical trial tested a multicomponent adherence intervention (TEAMLET) that used linked electronic health record and pharmacy data to identify patients with uncontrolled hypertension and medication nonadherence and then delivered team-based care to address adherence barriers. The study assessed whether this scalable, data-driven approach improved medication adherence and related hypertension outcomes compared with usual care. If effective, the strategy could meaningfully reduce nonadherence in hypertension by enabling point-of-care identification and targeted support.

Blecker S, Mann DM, Martinez TR et al. · JAMA cardiology · (2025) · 5 citations · View on PubMed ↗ · Free PDF ↗

INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia.

The INTEGRATE project developed international consensus guidelines for algorithmic pharmacological treatment of schizophrenia by synthesizing evidence via an umbrella review, expert workshops, a consensus survey, and lived-experience focus groups. It produced a consensus algorithmic guideline and associated digital tool intended to standardize treatment across UN regions. Scientifically and clinically, it aims to improve consistency and comprehensiveness of schizophrenia medication decision-making while addressing physical health comorbidities.

McCutcheon RA, Pillinger T, Varvari I et al. · The lancet. Psychiatry · (2025) · 54 citations · View on PubMed ↗ · Free PDF ↗

Effects of intermittent pneumatic compression on delayed onset muscle soreness and recovery of muscular fatigue.

This randomized controlled trial evaluated whether intermittent pneumatic compression (IPC) affects delayed onset muscle soreness (DOMS) and recovery of muscular fatigue after plyometric exercise in 20 healthy untrained male college students. Participants were assigned to an IPC group (n=10) or control group (n=10), with DOMS induced by plyometric performance and outcomes tracked during recovery (details truncated in the abstract). If IPC reduced DOMS and improved fatigue recovery, it would support a practical post-exercise intervention to enhance athletic recovery.

Gu Z, Dai J, Xu K et al. · PM & R : the journal of injury, function, and rehabilitation · (2025) · 3 citations · View on PubMed ↗ · Free PDF ↗

The role of nutrition in wound healing and implications for nursing practice.

This narrative review examined how nutrition affects each stage of wound healing (hemostasis, inflammation, proliferation, and remodeling) and translated the evidence into nursing practice. It concluded that specific nutrients—especially proteins, vitamins A/C/E/K, and minerals such as zinc, iron, copper, and manganese—are critical for collagen synthesis, immune function, and cellular activity. The review is clinically significant because it provides actionable guidance for nurses to assess nutritional status and implement targeted dietary interventions to improve wound outcomes.

Hill B, Mitchell A, Szydlowska A et al. · British journal of nursing (Mark Allen Publishing) · (2025) · 6 citations · View on PubMed ↗

Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation.

This study developed and validated a clinical guideline for using metformin to prevent antipsychotic-induced weight gain (AIWG) in people with severe mental illness (SMI). The consensus process using AGREE II supported metformin as the most effective pharmacologic option among those studied for AIWG prevention, addressing the gap between evidence and practice. Establishing a validated metformin guideline could improve weight-management outcomes and reduce obesity-related harms in SMI treated with antipsychotics.

Carolan A, Hynes-Ryan C, Agarwal SM et al. · Schizophrenia bulletin · (2025) · 37 citations · View on PubMed ↗ · Free PDF ↗

Transforming nursing work environments: the impact of organizational culture on work-related stress among nurses: a systematic review.

This systematic review examined how organizational culture in nursing work environments influences work-related stress among nurses. Across included studies, organizational culture factors were consistently associated with nurses’ stress levels, with the review highlighting that this relationship remains under-researched and inconsistently measured. Clarifying these culture–stress links can inform targeted workplace interventions to improve nurse well-being and potentially patient care quality.

Kiptulon EK, Elmadani M, Limungi GM et al. · BMC health services research · (2024) · 52 citations · View on PubMed ↗ · Free PDF ↗

Correlation between ethical sensitivity and humanistic care ability among undergraduate nursing students: a cross-sectional study.

This cross-sectional study surveyed 656 undergraduate nursing students to assess the correlation between ethical sensitivity and humanistic care ability using validated questionnaires. Ethical sensitivity scores were positively correlated with humanistic care ability (r=0.426, P<0.0 as reported in the abstract). The finding supports incorporating ethics-focused training to strengthen humanistic care competencies during nursing education.

Zhang Y, Li S, Huang Y et al. · BMC nursing · (2024) · 8 citations · View on PubMed ↗ · Free PDF ↗

Large Language Model Influence on Diagnostic Reasoning: A Randomized Clinical Trial.

This randomized clinical trial tested whether using a large language model (LLM) improves physicians’ diagnostic reasoning compared with conventional resources. Physicians’ diagnostic reasoning performance was evaluated in a single-blind trial across multiple academic medical institutions with family medicine, internal medicine, and emergency medicine trainees. If beneficial (or not), the findings directly inform how LLM tools should be integrated into clinical decision-making workflows.

Goh E, Gallo R, Hom J et al. · JAMA network open · (2024) · 492 citations · View on PubMed ↗ · Free PDF ↗

Optimizing radiation safety in dentistry: Clinical recommendations and regulatory considerations.

This 2024 review summarized evidence-based clinical recommendations and regulatory considerations for radiation safety in dentistry, covering dental radiography and cone-beam computed tomography (CBCT). It synthesizes guidance on appropriate imaging practices and strategies to reduce patient and occupational radiation exposure. The significance is practical: it supports safer imaging protocols that balance diagnostic benefit with minimized radiation risk for patients and dental healthcare providers.

Benavides E, Krecioch JR, Connolly RT et al. · Journal of the American Dental Association (1939) · (2024) · 60 citations · View on PubMed ↗ · Free PDF ↗

Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review.

This systematic review evaluated the content and quality of existing monitoring guidelines for clozapine-induced adverse effects in patients treated with clozapine for treatment-resistant schizophrenia. It focused on whether guidelines adequately cover serious metabolic, neuroendocrine, cardiovascular, and gastrointestinal monitoring recommendations. The significance lies in identifying gaps in monitoring frameworks to improve patient safety and early detection of clozapine-related harms.

Smessaert S, Detraux J, Desplenter F et al. · CNS drugs · (2024) · 17 citations · View on PubMed ↗ · Free PDF ↗

ACVIM Consensus Statement on the management of status epilepticus and cluster seizures in dogs and cats.

This ACVIM consensus statement studied the evidence base for treating seizure emergencies—status epilepticus and cluster seizures—in dogs and cats, synthesizing recommendations from peer-reviewed literature. The key finding was an expert-agreed, evidence-based guideline framework intended to standardize management despite prior variability and lack of official directives. Scientifically and clinically, it provides practical treatment guidance to reduce morbidity and mortality in veterinary patients with rapidly progressive, drug-resistant seizure emergencies.

Charalambous M, Muñana K, Patterson EE et al. · Journal of veterinary internal medicine · (2024) · 24 citations · View on PubMed ↗ · Free PDF ↗

---

---

Generated automatically on May 12, 2026 from PubMed’s trending articles. Summaries are AI-generated; always consult the original publication for clinical or research decisions.